SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Matrix Pharmaceutical (MATX)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
240 9 0 MATX
Emcee:  Steve Powers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
140 D. Root, Hope your vacation went well and was relaxing. No need to explain tobiowa-6/16/1997
139 'Sorry that it took me a while. I have been on vacation, with only one timSleepman-6/16/1997
138 Biowa, I agree that they should be developing alliances with companies developiVector1-6/14/1997
137 Biowa, regarding this discussion, I am copying this from my post on the VD thAndrew H-6/13/1997
136 V1, Good points, much less verbose than mine. <<...the delivery technolbiowa-6/13/1997
135 Interesting discusion. Couple of thoughts. 1. At about 7 per share MATX doesn&Vector1-6/12/1997
134 D. Root, Welcome back, glad to hear you're up for a little debate. Unfortbiowa-6/12/1997
133 I love a good debate! To clarify what I previously wrote: MATX's technoloSleepman-6/12/1997
132 D. Root, I'm interested in your reasoning in dismissing MATX technology asbiowa-6/6/1997
131 Matrix Pharmaceutical's AccuSite Injectable Gel Recommended for Marketing ARocketman-6/3/1997
130 Sounds like pretty standard take care of the employees stock stuff. I'm alRocketman-6/3/1997
129 Don't know how that message repeated itself. I came in to thank you D. RooMOLLYSUE-6/3/1997
128 D. Root what makes you question Matrix products longevity? I would think herpesMOLLYSUE-6/3/1997
127 Cancer will certainly be with us for a long time. MATX's technology is aimeSleepman-5/29/1997
126 D. Root what makes you question Matrix products longevity? I would think herpesMOLLYSUE-5/28/1997
125 It seems that they settled. From what I know, there was no monetary exchange.Sleepman-5/26/1997
124 To all, Any word on the MATX/CGEN trial? biowabiowa-5/20/1997
123 not me. I got out of this stock last December for tax purposes. - SteveSteve Powers-5/5/1997
122 I heard that Matrix's trial vs. Collagen opens today after jury selection lJonathan Rothschild-5/5/1997
121 I don't tend to project dollar or % gain estimates, especially publically. Rocketman-5/5/1997
120 Michael : IMO MATX would bounce up to $12-$14 per share, where it was prior toR F B, Jr.-5/4/1997
119 I've been reading an article in International Business (March '97) abouMichael Davis-5/4/1997
118 Vector1 made the same observation that they seem to not look out for their sharRocketman-5/1/1997
117 Look at the severence Palefsky received, 2MM for resigning from Collagen and stJonathan Rothschild-5/1/1997
116 Litigation from MATX 10K of 3/25/97 On December 21, 1994, Collagen fRocketman-4/30/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News